• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

企图自杀时的拉考酰胺中毒。

Lacosamide intoxication in attempted suicide.

机构信息

Department of Neurology, University of Marburg, Marburg, Germany.

出版信息

Epilepsy Behav. 2010 Apr;17(4):549-51. doi: 10.1016/j.yebeh.2010.01.007. Epub 2010 Feb 18.

DOI:10.1016/j.yebeh.2010.01.007
PMID:20171144
Abstract

The anticonvulsant drug lacosamide selectively enhances slow inactivation of voltage-gated sodium channels and has been shown to be an effective add-on treatment for partial-onset seizures. Common adverse events (frequency 10%) of lacosamide doses up to 600 mg/day include nonspecific central nervous system effects (e.g., dizziness, ataxia, diplopia, and somnolence). There are no human data regarding the safety of very high dosages of lacosamide. We report the clinical course of a patient with bitemporal epilepsy who ingested 12 g of lacosamide, 56 g of gabapentin, 2g of topiramate, and 2.8 g of zonisamide during a suicide attempt. The patient was found comatose and experienced repeated generalized tonic-clonic seizures, aspiration with subsequent pneumonia, hypotension, and an increase in PR interval. Complete physical recovery occurred after several days of supportive treatment. We conclude that intoxication with lacosamide, in combination with overdoses of multiple AEDs, can be survived without sequelae, even after ingestion of 12 g lacosamide.

摘要

抗惊厥药物拉科酰胺选择性地增强电压门控钠离子通道的缓慢失活,已被证明是治疗部分发作性癫痫的有效附加治疗药物。拉科酰胺剂量高达 600mg/天的常见不良反应(频率为 10%)包括非特异性中枢神经系统效应(如头晕、共济失调、复视和嗜睡)。目前尚无关于拉科酰胺极高剂量安全性的人体数据。我们报告了一名颞叶癫痫患者的临床病程,该患者在试图自杀时摄入了 12g 拉科酰胺、56g 加巴喷丁、2g 托吡酯和 2.8g 左乙拉西坦。该患者被发现昏迷,并经历了反复全身性强直阵挛发作、随后的肺炎吸入、低血压和 PR 间隔增加。经过几天的支持治疗后,患者完全康复。我们得出结论,即使摄入 12g 拉科酰胺,与多种 AED 过量联合使用的拉科酰胺中毒也可以存活而没有后遗症。

相似文献

1
Lacosamide intoxication in attempted suicide.企图自杀时的拉考酰胺中毒。
Epilepsy Behav. 2010 Apr;17(4):549-51. doi: 10.1016/j.yebeh.2010.01.007. Epub 2010 Feb 18.
2
Lacosamide: an adjunctive agent for partial-onset seizures and potential therapy for neuropathic pain.拉科酰胺:部分发作性癫痫的辅助治疗药物,也是治疗神经病理性疼痛的潜在药物。
Ann Pharmacother. 2009 Nov;43(11):1809-17. doi: 10.1345/aph.1M303. Epub 2009 Oct 20.
3
Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures.静脉注射拉考酰胺短期替代部分发作性癫痫的口服拉考酰胺。
Epilepsia. 2010 Jun;51(6):951-7. doi: 10.1111/j.1528-1167.2009.02463.x. Epub 2009 Dec 22.
4
Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures.拉科酰胺:部分性发作的药理学、作用机制以及汇总的疗效和安全性数据
Expert Rev Neurother. 2009 Jan;9(1):33-42. doi: 10.1586/14737175.9.1.33.
5
Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures.在部分发作性癫痫患者中,添加左乙拉西坦静脉负荷剂量的安全性和耐受性。
Epilepsia. 2013 Jan;54(1):58-65. doi: 10.1111/j.1528-1167.2012.03543.x. Epub 2012 Jun 18.
6
Minimizing pharmacodynamic interactions of high doses of lacosamide.尽量减少高剂量拉考沙胺的药效学相互作用。
Acta Neurol Scand. 2012 Apr;125(4):228-33. doi: 10.1111/j.1600-0404.2011.01619.x. Epub 2011 Nov 10.
7
Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.辅助使用拉科酰胺治疗部分性发作:一项随机对照试验的疗效和安全性结果。
Epilepsia. 2009 Mar;50(3):443-53. doi: 10.1111/j.1528-1167.2008.01951.x. Epub 2009 Jan 17.
8
Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy.拉科酰胺是一种新型抗惊厥药物,在啮齿类癫痫模型中显示出疗效且安全范围广。
Epilepsy Res. 2007 May;74(2-3):147-54. doi: 10.1016/j.eplepsyres.2007.03.004. Epub 2007 Apr 12.
9
Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.非肠道用拉考酰胺治疗难治性惊厥性癫痫持续状态的成功。
Epilepsia. 2010 Feb;51(2):316-7. doi: 10.1111/j.1528-1167.2009.02256.x. Epub 2009 Aug 8.
10
The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.研究性抗惊厥药物拉科酰胺可选择性增强电压门控性钠通道的缓慢失活。
Mol Pharmacol. 2008 Jan;73(1):157-69. doi: 10.1124/mol.107.039867. Epub 2007 Oct 16.

引用本文的文献

1
Severe Bradycardia and Shock With Delayed Onset Due to Lacosamide Overdose: A Case Report.拉科酰胺过量导致的严重心动过缓和延迟性休克:一例报告
Cureus. 2025 Feb 20;17(2):e79381. doi: 10.7759/cureus.79381. eCollection 2025 Feb.
2
Topiramate intoxications & hemodialysis - Literature review and the first case report of a massive suicidal intoxication treated with hemodialysis.托吡酯中毒与血液透析——文献综述及首例血液透析治疗大量自杀性中毒病例报告
Toxicol Rep. 2022 Aug 12;9:1639-1646. doi: 10.1016/j.toxrep.2022.08.004. eCollection 2022.
3
Lacosamide poisoning improved by hemodialysis.
通过血液透析,拉科酰胺中毒情况得到改善。
Acute Med Surg. 2022 Aug 1;9(1):e775. doi: 10.1002/ams2.775. eCollection 2022 Jan-Dec.
4
New Methods Used in Pharmacokinetics and Therapeutic Monitoring of the First and Newer Generations of Antiepileptic Drugs (AEDs).新一代抗癫痫药物(AEDs)药代动力学和治疗监测中使用的新方法。
Molecules. 2020 Nov 2;25(21):5083. doi: 10.3390/molecules25215083.
5
Lacosamide: a Study of Exposures Reported to US Poison Centers over a 9-Year Period.拉考酰胺:一项为期 9 年的美国中毒控制中心报告暴露情况的研究。
J Med Toxicol. 2019 Oct;15(4):271-275. doi: 10.1007/s13181-019-00717-y. Epub 2019 Jul 8.
6
The Pharmacology and Toxicology of Third-Generation Anticonvulsant Drugs.第三代抗惊厥药物的药理学与毒理学
J Med Toxicol. 2017 Dec;13(4):329-342. doi: 10.1007/s13181-017-0626-4. Epub 2017 Aug 16.
7
The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experience.拉科酰胺作为单药治疗及辅助治疗用于局灶性癫痫的疗效及其在癫痫持续状态中的应用:临床试验证据与经验
Ther Adv Neurol Disord. 2017 Feb;10(2):103-126. doi: 10.1177/1756285616675777. Epub 2016 Nov 29.
8
Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain.拉科酰胺在西班牙进行的一项前瞻性、开放标签、观察性、多中心研究,评估其在 130 名 16 岁以下难治性癫痫患者联合治疗中的疗效和耐受性。
Drugs R D. 2012 Dec 1;12(4):187-97. doi: 10.2165/11636260-000000000-00000.
9
Novel medications for epilepsy.新型抗癫痫药物。
Drugs. 2011 Nov 12;71(16):2151-78. doi: 10.2165/11594640-000000000-00000.